Sign In
Buy GMED
$77.95
-0.300 (-0.383%)
At Close: Jun 03, 2026
Globus Medical (GMED) Q2 Earnings Top Estimates, '24 View Up
11:30am, Wednesday, 07'th Aug 2024
Globus Medical (GMED) delivers massive sales and earnings growth in the second quarter of 2024. However, margins contract.
Globus Medical, Inc. (GMED) Q2 2024 Earnings Call Transcript
11:27pm, Tuesday, 06'th Aug 2024
Globus Medical, Inc. (NYSE:GMED ) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Brian Kearns - SVP, Business Development and IR Daniel Scavilla - President and CEO Ke
Globus Medical (GMED) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
07:00pm, Tuesday, 06'th Aug 2024
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street es
Globus Medical (GMED) Q2 Earnings and Revenues Beat Estimates
06:41pm, Tuesday, 06'th Aug 2024
Globus Medical (GMED) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.68 per share. This compares to earnings of $0.63 per share a year ago.
Globus Medical Reports Second Quarter 2024 Results
04:15pm, Tuesday, 06'th Aug 2024
AUDUBON, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 20
Globus Medical (GMED) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
10:21am, Monday, 05'th Aug 2024
Get a deeper insight into the potential performance of Globus Medical (GMED) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates fo
Globus Medical (GMED) Global Sales, Innovation Aid Growth
11:41am, Friday, 19'th Jul 2024
In line with the company's business strategy to focus on its integrated product development, Globus Medical (GMED) is consistently making efforts in research and development.
Globus Medical (GMED) Gets FDA Nod for ExcelsiusFlex, ACTIFY 3D
10:35am, Thursday, 18'th Jul 2024
Globus Medical (GMED) gets the FDA 510(k) clearance for its ExcelsiusFlex with Total Knee Arthroplasty application and ACTIFY 3D Total Knee System.
Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System
08:30am, Wednesday, 17'th Jul 2024
AUDUBON, Pa., July 17, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it recently received 510(k) clearance by the U.S. Food a
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
04:30pm, Tuesday, 16'th Jul 2024
AUDUBON, Pa., July 16, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30,
Here's Why Globus Medical (GMED) is a Strong Growth Stock
10:46am, Friday, 12'th Jul 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Globus Medical, Inc. (GMED) Hits Fresh High: Is There Still Room to Run?
10:15am, Friday, 12'th Jul 2024
Globus Medical (GMED) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
GMED vs. SONVY: Which Stock Is the Better Value Option?
12:46pm, Wednesday, 10'th Jul 2024
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and SONOVA HOLDING (SONVY). But which of these two stocks is more attractive t
Here's Why Globus Medical (GMED) is a Strong Value Stock
10:41am, Wednesday, 10'th Jul 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term
10:51am, Monday, 17'th Jun 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
